Money

Arthritis drug Humira’s two-decade reign ends as Amgen launches competing biosimilar

Ken Alltucker, USA TODAYComments Off on Arthritis drug Humira’s two-decade reign ends as Amgen launches competing biosimilar

The price of Amgen's rheumatoid arthritis drug called Amjevita is up to 55% less than the widely-prescribed Humira.

     
Ken Alltucker, USA TODAY
http://api-internal.usatoday.com.akadns.net

Related Articles
Money

Former Rep. Harold Ford Jr. fired for alleged ‘misconduct;’ denies wrongdoing

USA TODAY NETWORK – Tennessee

Morgan Stanley said the former Tennessee congressman was terminated for ‘conduct inconsistent with our values and in violation of our policies.’
Featured Money

Bitcoin tops $16,000, and its $271B market value passes Home Depot’s

USA TODAY

The cryptocurrency’s rise in price makes it more valuable than all but 12 of the 500 companies in the S&P 500 stock index.
Money

4 money-saving strategies from spouses who bank 85% of their income

CNBC

Some couples live modestly, choosing to save and invest about 85% of their income.